Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $94.1000 (-4.3%) ($92.9200 - $97.7700) on Thu. May. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.4% (three month average) | RSI | 48 | Latest Price | $94.1000(-4.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.8% a day on average for past five trading days. | Weekly Trend | LGND advances 1.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(53%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -3.2% in a week (0% probabilities). VIXM(-24%) UUP(-17%) VXX(-16%) UNG(-2%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.2% (StdDev 6.4%) | Hourly BBV | 0 () | Intraday Trend | -2.7% | | | |
|
Resistance Level | $98.25 | 5 Day Moving Average | $100.97(-6.8%) | 10 Day Moving Average | $99.88(-5.79%) | 20 Day Moving Average | $98.25(-4.22%) | To recent high | -12.8% | To recent low | 48.5% | Market Cap | $1.512b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |